Skip to main content
OCS logo
OCS
(NASDAQ)
Oculis Holding AG
$11.21-- (--)
Loading... - Market loading

Oculis Holding (OCS) Stock Price & Financial Analysis

Oculis Holding Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$11.17 - $12.05
52-Week High$34.48
52-Week Low$11.17
Open$11.67
Volume869.42K
Average Volume (3M)858.15K
Market Cap619.40M
Shares Outstanding52.36M
Price to Sales (P/S)624.85
Price to Book (P/B)2.51
EV/EBITDA-5.31
Revenue (TTM)991.27K
Net Income (TTM)-124.10M
Free Cash Flow (TTM)-84.17M
EPS (TTM)$-2.38
Profit Margin-12519.43%
Operating Margin-10383.03%
Return on Equity (ROE)-50.32%
Debt to Equity0.01
50-Day MA$26.44
200-Day MA$23.09
52-Week Change-42.69%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Oculis Holding

What is the current stock price for OCS?

As of the latest trading session, OCS stock trades at $11.21. The 52-week range is $11.17–$34.48, with a day range of $11.17–$12.04.

What is the P/E ratio for OCS?

The P/E ratio (Price-to-Earnings) for OCS is shown in the Key Statistics section. This valuation metric helps compare Oculis Holding AG to industry peers.

Does OCS pay dividends?

Oculis Holding does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for OCS?

Based on 1 analyst, the consensus for OCS is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of OCS?

Oculis Holding's market capitalization is $586.9M, classifying it as a small-cap company. Oculis Holding operates in the Healthcare sector within the Biotechnology industry.